December 2011. Volume 7. Number 4

Immunotherapy in childhood

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

ED | Editorial

Authors: Martínez-Cañavate Burgos A1, Álvaro M2, Larramona H3, Lucas Moreno JM4, Mesa del Castillo M5, Sancha J6, Tabar Purroy A7.
1H. Materno-Infantil Virgen de las Nieves. Granada. España.
2Hospital Sant Joan de Déu. Esplugues de Llobregat. Barcelona. España.
3Hospital Parc Tauli. Barcelona. Sabadell. España.
4Hospital de la Arrixaca. Murcia. España.
5Hospital de San Lorenzo del Escorial. San Lorenzo del Escorial. Madrid. España.
6Hospital Virgen del Camino. Sanlucar de Barrameda. Cádiz. España.
7Hospital Virgen del Camino. Pamplona. España.
Correspondence: Ana Martínez-Cañavate Burgos. Email: anamartinezcanavate@gmail.com
Publication date: 01/12/2011

How to cite this article

Martínez-Cañavate Burgos A, Alvaro M, Larramona H, Lucas Moreno JM, Mesa del Castillo AM, Sancha J, et al; Grupo de Trabajo de Inmunoterapia de la SEICAP.
Indicaciones de la inmunoterapia en la edad pediátrica. Evid Pediatr. 2011;7:78.

ED | Editorial

Authors: Martínez-Cañavate Burgos A1, Álvaro M2, Larramona H3, Lucas Moreno JM4, Mesa del Castillo M5, Sancha J6, Tabar Purroy A7.
1H. Materno-Infantil Virgen de las Nieves. Granada. España.
2Hospital Sant Joan de Déu. Esplugues de Llobregat. Barcelona. España.
3Hospital Parc Tauli. Barcelona. Sabadell. España.
4Hospital de la Arrixaca. Murcia. España.
5Hospital de San Lorenzo del Escorial. San Lorenzo del Escorial. Madrid. España.
6Hospital Virgen del Camino. Sanlucar de Barrameda. Cádiz. España.
7Hospital Virgen del Camino. Pamplona. España.
Correspondence: Ana Martínez-Cañavate Burgos. Email: anamartinezcanavate@gmail.com
Publication date: 01/12/2011

How to cite this article

Martínez-Cañavate Burgos A, Alvaro M, Larramona H, Lucas Moreno JM, Mesa del Castillo AM, Sancha J, et al; Grupo de Trabajo de Inmunoterapia de la SEICAP.
Indicaciones de la inmunoterapia en la edad pediátrica. Evid Pediatr. 2011;7:78.

References

  1. Noon L. Prophylactic inoculation against hay fever. Lancet. 1911;1:1572-3.
  2. Artículo de Opinión de la O.M.S. Inmunoterapia con alérgenos: Vacunas terapéuticas para las enfermedades alérgicas. Ginebra. 27-29 de Enero, 1997. Allergy. 1998;44:2-42.
  3. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2003;(4):CD001186.
  4. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007;(1):CD001936.
  5. Penagos M, Passalacqua G, Compalati E, Baena-Cagnani CE, Orozco S, Pedroza A  et al. Metaanalysis of the Efficacy of Sublingual Immunotherapy in the Treatment of Allergic Asthma in Pediatric Patients, 3 to 18 years of age. Chest. 2008;133:599-609.
  6. Abramson MJ, Puy RM,Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database of Systematic Reviews 2010, Issue 8. Art. No.: CD001186. DOI: 10.1002/14651858.CD001186.pub2.
  7. GEMA 2009. Guía española para el manejo del asma. Madrid: 2009 [en línea] [fecha de consulta: 28 - XI - 2011]. Disponible en: http://www.gemasma.com
  8. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN* and AllerGen**). Allergy. 2008;63:8-160.
  9. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med. 1995;151:969-74.
  10. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2003;(4):CD001186.
  11. Bernstein DI, Wanner M, Borish L,Liss GM, Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol. 2004;113:1129-36.
  12. Moreno C, Cuesta Herranz J, Fernández Tavora L, Álvarez Cuesta E. Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy. 2004;34:527-31.
  13. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A et al. The PAT investigator group. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62:943-8.
  14.  Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A sixyear follow-up study. Clin Exp Allergy. 2001;31:1392-7.
  15. Durham SR, Walker SM, Varga EM, Jacobson MR, O’Brien F, Noble W, et al. Long-term clinical efficacy of grasspollen immunotherapy. N Engl J Med. 1999;341:468-75.
  16. Adkinson NF, Eggleston PA, Eney D, Goldstein EO, Schuberth KC, Bacon JR et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med. 1997;336:324-31.
  17. Blumberga G, Groes L, Haugaard L, Dahl R. Steroid-sparing effect of subcutaneous SQ-standardized specific immunotherapy in moderate and severe house dust mite allergic asthmatics. Allergy. 2006;61:843-8.
  18. Maestrelli P, Zanolla L, Pozzan M, Fabbri LM, on behalf of the Regione Veneto Study Group. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite. J Allergy Clin Immunol. 2004;113:643-9.
  19. Pham-Thi N, Scheinmann P, Fadel R, Combegias A, Andre C, and the Study Group. Assessment of sublingual immunotherapy efficacy in children with house dust miteinduced allergic asthma optimally controlled by pharmacologic treatment and miteavoidance measures. Pediatr Allergy Immunol. 2007;18:47-57.
  20. Ozdemir C, Yazi D, Gocmen I, Yesil O, Aydrogan M, Semic-Jusufagic A et al. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol. 2007;18:508-15.
  21. Bonifazi F, Jutel M, Biló BM, Birnbaum J, Muller U; EAACI Interest Group on Insect Venom Hypersensitivity. Prevention and treatment of Hymenoptera venom allergy: guidelines for clinical practice. Allergy. 2005;60:1459-70.
01/12/2011

Linked Comment